+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ceftazidime"

Antibiotic Resistance Global Market Report 2024 - Product Thumbnail Image

Antibiotic Resistance Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Antibiotics Global Market Report 2024 - Product Thumbnail Image

Antibiotics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Cephalosporin Markets in China - Product Thumbnail Image

Cephalosporin Markets in China

  • Report
  • October 2023
  • 270 Pages
  • China
From
Cephalosporin Industry Forecasts - China Focus - Product Thumbnail Image

Cephalosporin Industry Forecasts - China Focus

  • Report
  • October 2023
  • 135 Pages
  • China
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Ceftazidime is a third-generation cephalosporin antibiotic used to treat a wide range of bacterial infections. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria. Ceftazidime is commonly used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. It is also used to treat infections caused by certain types of bacteria that are resistant to other antibiotics. Ceftazidime is often used in combination with other antibiotics to treat more serious infections. Ceftazidime is available in both injectable and oral forms. It is typically administered intravenously in a hospital setting, but can also be taken orally for certain infections. Ceftazidime is generally well tolerated, but can cause side effects such as nausea, vomiting, and diarrhea. The market for Ceftazidime is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Sanofi. Show Less Read more